Synapse - Find an Expert

5608 Results

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Journal Article

Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
Molecular Oncology (2020)

Fulltext@MSK | Save

Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome

Journal Article

Breen, K. E.; Carlo, M. I.; Kemel, Y.; Maio, A.; Chen, Y. B.; Zhang, L.; Ceyhan-Birsoy, O.; Mandelker, D.
Molecular Genetics and Genomic Medicine (2020)

Fulltext@MSK | Save

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial

Journal Article

Motzer, R. J.; Escudier, B.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Plimack, E. R.; Procopio, G.; McDermott, D. F.; more...
Cancer (2020)

Fulltext@MSK | Save

Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver

Journal Article

El Dika, I.; Bowman, A. S.; Berger, M. F.; Capanu, M.; Chou, J. F.; Benayed, R.; Zehir, A.; Shia, J.; O’Reilly, E. M.; Klimstra, D. S.; more...
Cancer (2020)

Fulltext@MSK | Save

Characterization of on-target adverse events caused by TRK inhibitor therapy

Journal Article

Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
Annals of Oncology (2020)

Fulltext@MSK | Save

Updated efficacy results from the JAVELIN Renal 101 trial: First-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma